Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Podcast: Stem cell therapy for PD - A new era for managing Parkinson’s disease?
dec 2023 | Bewegingsstoornissen